
CAS 2095849-04-8
:Formule :C25H20F3N5O2
InChI :InChI=1S/C25H20F3N5O2/c1-15-6-7-21(31-23(34)16-4-3-5-20(9-16)25(26,27)28)10-22(15)32-24(35)18-8-17(11-29-12-18)19-13-30-33(2)14-19/h3-14H,1-2H3,(H,31,34)(H,32,35)
Code InChI :BMEXIUCHJUGPRB-UHFFFAOYSA-N
SMILES :CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)NC(=O)C3=CN=CC(=C3)C4=CN(N=C4)C
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
6 produits trouvés.
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
CSF1R-IN-1
CAS :CSF1R-IN-1 is a CSF1R inhibitor with IC50 of 0.5 nM.Formule :C25H20F3N5O2Degré de pureté :97.02% - 98.17%Couleur et forme :SolidMasse moléculaire :479.45385-(1-Methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide
CAS :5-(1-Methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamideFormule :C25H20F3N5O2Degré de pureté :99%Masse moléculaire :479.455-(1-Methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide
CAS :Formule :C25H20F3N5O2Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :479.4538CSF1R-IN-1
CAS :5-(1-Methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamideFormule :C25H20F3N5O2Degré de pureté :99%Masse moléculaire :479.45CSF1R-IN-1
CAS :CSF1R-IN-1 is a small molecule inhibitor, which is derived from synthetic chemical processes designed to selectively target the colony-stimulating factor 1 receptor (CSF1R) tyrosine kinase. The primary mode of action of CSF1R-IN-1 involves the inhibition of the CSF1R signaling pathway. This pathway is crucial for the regulation of the development and function of macrophages, which are vital for immune response and homeostasis. By selectively binding to the ATP-binding site of CSF1R, CSF1R-IN-1 effectively blocks the receptor's activity, thus reducing unwanted macrophage-mediated inflammation and proliferation.Formule :C25H20F3N5O2Degré de pureté :Min. 95%Masse moléculaire :479.5 g/mol




